OlysioActive Ingredient(s): Simeprevir
FDA Approved: * November 22, 2013
Pharm Company: * JANSSEN RES AND DEV
Simeprevir, sold under the trade names Olysio among others, is a medication used in combination with other medications for the treatment of hepatitis C. It is specifically used for hepatitis C genotype 1 and 4. Medications it is used with include sofosbuvir or ribavirin and peginterferon-alfa. Cure rates are in 80s to 90s percent. It may be used in those who also have HIV/AIDS.&am... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.